NEO-214

N/A

Report date: 2023/05/22 10:16:43
NME

Base Information

Drug NameNEO-214
Drug Alias NamePerillyl alcohol-rolipramPOH-rolipram
ClassificationSmall molecules
Mechanisms of ActionGTPase Ras inhibitorsTumor necrosis factor receptor superfamily member 10B agonistsApoptosis stimulants
TargetsGTPase RasTumor necrosis factor receptor superfamily member 10B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeonc Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeonc Technologies Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A